Filing Details

Accession Number:
0001140361-19-002080
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-31 07:48:26
Reporting Period:
2019-01-30
Accepted Time:
2019-01-31 07:48:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1228627 Rexahn Pharmaceuticals Inc. RNN Pharmaceutical Preparations (2834) 113516358
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1661400 Lisa Nolan C/O Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road, Suite 455
Rockville MD 20850
Chief Business Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-30 20,000 $0.65 21,625 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price of $0.648 per share represents a weighted average of purchase prices ranging from $0.635 to $0.650 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price